Get started
Cerus CorporationCerus CorporationCerus Corporation

Cerus Corporation

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪253.78 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.09 EUR
Net income (FY)
‪−20.21 M‬ EUR
Revenue (FY)
‪174.14 M‬ EUR
Shares float
‪182.07 M‬
Beta (1Y)
1.93

Employees


Employees (FY)
281
Change (1Y)
−7 −2.43%
Revenue / Employee (1Y)
‪619.70 K‬ EUR
Net income / Employee (1Y)
‪−71.91 K‬ EUR

About Cerus Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
William Mariner Greenman
Website
cerus.com
Headquarters
Concord
Founded
1991
ISIN
US1570851014
FIGI
BBG01JLCM324
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Check out other big names from the same industry as CU2.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


ARKK
ARK Innovation ETF
Weight
0.19%
Market value
‪14.62 M‬
USD
ARKG
ARK Genomic Revolution ETF
Weight
0.79%
Market value
‪9.70 M‬
USD
IWO
iShares Russell 2000 Growth ETF
Weight
0.02%
Market value
‪2.35 M‬
USD
FESM
Fidelity Enhanced Small Cap ETF
Weight
0.04%
Market value
‪1.08 M‬
USD
SMLF
iShares U.S. SmallCap Equity Factor ETF
Weight
0.04%
Market value
‪963.23 K‬
USD
VHT
Vanguard Health Care ETF
Weight
0.01%
Market value
‪893.94 K‬
USD
IWC
iShares Micro-Cap ETF
Weight
0.06%
Market value
‪625.78 K‬
USD
GSSC
TR Activebeta US Small Cap Equity ETF
Weight
0.05%
Market value
‪311.02 K‬
USD
VTWG
Vanguard Russell 2000 Growth ETF
Weight
0.02%
Market value
‪256.45 K‬
USD
QQQS
Invesco NASDAQ Future Gen 200 ETF
Weight
0.51%
Market value
‪59.66 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of CU2 is 1.26 EUR — it has decreased by −1.81% in the past 24 hours. Watch Cerus Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Cerus Corporation stocks are traded under the ticker CU2.
CU2 stock has fallen by −1.57% compared to the previous week, the month change is a −7.54% fall, over the last year Cerus Corporation has showed a −10.88% decrease.
We've gathered analysts' opinions on Cerus Corporation future price: according to them, CU2 price has a max estimate of 4.45 EUR and a min estimate of 3.56 EUR. Watch CU2 chart and read a more detailed Cerus Corporation stock forecast: see what analysts think of Cerus Corporation and suggest that you do with its stocks.
CU2 reached its all-time high on Mar 6, 2024 with the price of 2.31 EUR, and its all-time low was 0.98 EUR and was reached on Aug 21, 2025. View more price dynamics on CU2 chart.
See other stocks reaching their highest and lowest prices.
CU2 stock is 2.91% volatile and has beta coefficient of 1.93. Track Cerus Corporation stock price on the chart and check out the list of the most volatile stocks — is Cerus Corporation there?
Today Cerus Corporation has the market capitalization of ‪241.89 M‬, it has increased by 3.49% over the last week.
Yes, you can track Cerus Corporation financials in yearly and quarterly reports right on TradingView.
Cerus Corporation is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
CU2 earnings for the last quarter are −0.03 EUR per share, whereas the estimation was −0.02 EUR resulting in a −9.09% surprise. The estimated earnings for the next quarter are −0.02 EUR per share. See more details about Cerus Corporation earnings.
Cerus Corporation revenue for the last quarter amounts to ‪51.02 M‬ EUR, despite the estimated figure of ‪46.16 M‬ EUR. In the next quarter, revenue is expected to reach ‪49.25 M‬ EUR.
CU2 net income for the last quarter is ‪−4.84 M‬ EUR, while the quarter before that showed ‪−7.13 M‬ EUR of net income which accounts for 32.08% change. Track more Cerus Corporation financial stats to get the full picture.
No, CU2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 6, 2025, the company has 281 employees. See our rating of the largest employees — is Cerus Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cerus Corporation EBITDA is ‪−28.35 M‬ EUR, and current EBITDA margin is −18.46%. See more stats in Cerus Corporation financial statements.
Like other stocks, CU2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cerus Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cerus Corporation technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cerus Corporation stock shows the sell signal. See more of Cerus Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.